x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
News

Advarra Unveils New Website and United Brand

Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC) and research compliance services in North America, unveils a new website with a united brand.

Read Now
2 min. read
Read more
 
News

IRB Submissions to Advarra: Electronic Platform Routing and Data Migration

Beginning May 1, all new study submissions to Advarra’s IRB will be made through the Advarra Center for IRB Intelligence (CIRBI) Platform.

Read Now
1 min. read
Read more
 
News

IRB Services Announces Name Change

IRB Services, Canada’s largest independent research ethics board (REB), has changed its name to Advarra

Read Now
2 min. read
Read more
 
News

Second Delay Issued for Revisions to the Common Rule

US federal departments and agencies propose delaying general compliance date for Common Rule revisions for an additional 6 months, modifying the compliance date to January 21, 2019.

Read Now
1 min. read
Read more
 
News

ACRP Features Julie Blasingim in Clinical Researcher

Julie Blasingim, MBA, CIP, Director of IRB Reviews at Advarra, was featured in ARCP’s flagship journal, Clinical Researcher, which features peer-reviewed articles on the latest developments in clinical research.

Read Now
Read more
 
News

Falcon Consulting Announces Name Change to Advarra Consulting

Falcon Consulting Group, Inc., a leading global research quality and compliance company, has changed its name to Advarra Consulting, Inc.

Read Now
2 min. read
Read more
 
News

Electronic Platform Integration to Begin in May

Advarra will begin migrating legacy Schulman IRB study information into the Advarra electronic platform in May 2018. Clients will be contacted beginning in March to discuss the migration process and develop a transition plan.

Read Now
2 min. read
Read more
 
News

Note to File Re: Statement of Investigator, Form FDA 1572 2018

Effective 2/5, Advarra IRB serves as the IRB providing oversight for the study(ies) listed on 1572s as under Schulman IRB oversight.

Read Now
2 min. read
Read more
 
News

Applied Clinical Trials Quotes Advarra President and COO on Electronic Health Records for Clinical Research

Advarra's President and COO Jeff Wendel was quoted in How EHRs Facilitate Clinical Research from Applied Clinical Trials.

Read Now
Read more
 
News

Healthcare Businesswomen’s Association Names Robann Cunningham to Cincinnati Chapter Board

Robann Cunningham has been named to the Healthcare Businesswomen’s Association (HBA) Cincinnati Chapter Board as the Director-at-Large for the Programming Committee.

Read Now
1 min. read
Read more
 
News

Advarra and TransPerfect Form Strategic Language Services Partnership

TransPerfect Life Sciences announced today that it has been selected as the official language services provider for Advarra.

Read Now
2 min. read
Read more
 
News

Effective Date and General Compliance Date for Revised Common Rule Delayed 6 Months

The Department of Health and Human Services (HHS) and 15 other agencies have issued an Interim Final Rule (IFR) that applies a 6 month delay to the effective date and general compliance date of the revisions to the “Federal Policy for the Protection of Human Subjects” (also known as the Common Rule) originally published in the Federal Register on January 19, 2017 (82 FR 7149).

Read Now
1 min. read
Read more